LLY.SW

Eli Lilly and Company [LLY.SW] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

LLY.SW Stock Summary

Top 10 Correlated ETFs

LLY.SW


Top 10 Correlated Stocks

LLY.SW


In the News

LLY.SW Financial details

Company Rating
Strong Buy
Market Cap
627.11B
Income
5.24B
Revenue
34.12B
Book val./share
11.35
Cash/share
3.08
Dividend
4.52
Dividend %
0.76%
Employees
43K
Optionable
No
Shortable
Yes
Earnings
30 Apr 2024
P/E
107.98
Forward P/E
43.28
PEG
-75.17
P/S
18.45
P/B
48.01
P/C
214.29
P/FCF
-3588.47
Quick Ratio
0.58
Current Ratio
1.05
Debt / Equity
2.34
LT Debt / Equity
1.69
-
-
EPS (TTM)
5.63
EPS next Y
15.25
EPS next Q
-
EPS this Y
-15.98%
EPS next Y
171.03%
EPS next 5Y
171.03%
EPS last 5Y
2.66%
Revenue last 5Y
8.86%
Revenue Q/Q
-1.53%
EPS Q/Q
-3720.69%
-
-
-
-
SMA20
23.86%
SMA50
28.81%
SMA100
38.33%
Inst Own
-
Inst Trans
-
ROA
9%
ROE
45%
ROC
0.16%
Gross Margin
79%
Oper. Margin
18%
Profit Margin
16%
Payout
79%
Shs Outstand
996.3M
Shs Float
890.44M
-
-
-
-
Target Price
-
52W Range
296.0-740.0
52W High
-10.81%
52W Low
+122.97%
RSI
55.92
Rel Volume
0.01
Avg Volume
2.08K
Volume
24
Perf Week
-10.81%
Perf Month
21.1%
Perf Quarter
34.69%
Perf Half Y
34.69%
-
-
-
-
Beta
0.316
-
-
Volatility
9.9%, 65.74%
Prev Close
0%
Price
660
Change
0%

LLY.SW Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
23.3125.6529.6930.0435.94
Net income per share
4.846.475.856.575.52
Operating cash flow per share
5.056.797.617.464.47
Free cash flow per share
3.644.675.654.84-3.32
Cash per share
2.553.854.12.333.08
Book value per share
2.725.99.4211.2111.35
Tangible book value per share
-7.94-5.64-2.55-0.53-1.03
Share holders equity per share
2.725.99.4211.2111.35
Interest debt per share
16.9217.7218.0617.4427.08
Market cap
110.56B159.34B242.14B357.68B570.53B
Enterprise value
124.03B172.28B255.21B371.85B592.94B
P/E ratio
23.8425.7343.3857.28108.87
Price to sales ratio
4.956.498.5512.5316.72
POCF ratio
22.8624.5233.3550.49134.56
PFCF ratio
31.7435.6444.9577.75-181.01
P/B Ratio
42.4128.2426.9733.5952.96
PTB ratio
42.4128.2426.9733.5952.96
EV to sales
5.567.029.0113.0317.38
Enterprise value over EBITDA
18.7822.5529.239.4247.6
EV to operating cash flow
25.6426.5135.1552.49139.84
EV to free cash flow
35.6138.5447.3780.83-188.11
Earnings yield
0.040.040.020.020.01
Free cash flow yield
0.030.030.020.01-0.01
Debt to equity
6.062.941.881.522.34
Debt to assets
0.40.360.350.330.39
Net debt to EBITDA
2.041.691.51.51.8
Current ratio
1.161.41.231.050.94
Interest coverage
12.4216.8518.7121.4922.49
Income quality
0.581.051.31.130.81
Dividend Yield
0.020.020.010.010.01
Payout ratio
0.520.430.550.570.78
Sales general and administrative to revenue
0.280.250.230.230.2
Research and developement to revenue
0.250.250.250.250.27
Intangibles to total assets
0.260.240.240.230.19
Capex to operating cash flow
-0.28-0.31-0.26-0.35-1.74
Capex to revenue
-0.06-0.08-0.07-0.09-0.22
Capex to depreciation
-1.1-1.53-1.21-1.63-4.84
Stock based compensation to revenue
0.010.010.010.010.02
Graham number
17.2329.3135.2140.7137.54
ROIC
0.230.230.220.240.24
Return on tangible assets
0.160.170.150.160.1
Graham Net
-29.66-31.3-29.05-29.39-40.9
Working capital
1.93B4.98B3.4B896.3M-1.57B
Tangible asset value
-7.6B-5.39B-2.43B-504.2M-982.6M
Net current asset value
-22.88B-23.35B-21.2B-20.68B-27.42B
Invested capital
6.062.941.881.522.34
Average receivables
5.66B6.24B7.53B8.34B9.95B
Average payables
1.31B1.51B1.64B1.8B2.26B
Average inventory
3.14B3.59B3.93B4.1B5.04B
Days sales outstanding
90.62103.06104.75109.45121.25
Days payables outstanding
108.64106.9583.38106.29133.94
Days of inventory on hand
246.68264.95193.96237.27297.52
Receivables turnover
4.033.543.483.333.01
Payables turnover
3.363.414.383.432.73
Inventory turnover
1.481.381.881.541.23
ROE
1.781.10.620.590.49
Capex per share
-1.41-2.12-1.96-2.61-7.79

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
7.687.339.2110.569.85
Net income per share
2.041.421.95-0.062.31
Operating cash flow per share
1.661.820.72.43-0.33
Free cash flow per share
1.080.87-0.23-2.01-2.07
Cash per share
2.333.873.132.773.08
Book value per share
11.2111.7912.2612.4711.35
Tangible book value per share
-0.530.140.180.49-1.03
Share holders equity per share
11.2111.7912.2612.4711.35
Interest debt per share
17.182020.9822.5526.72
Market cap
357.68B322.18B416.83B482.22B570.53B
Enterprise value
371.85B337.52B432.96B500B592.94B
P/E ratio
46.1559.8959.1-2.1K65.14
Price to sales ratio
48.9846.2950.1550.7761
POCF ratio
226.42186.17659.65220.24-1.83K
PFCF ratio
349.26389.53-2.04K-266.17-290.64
P/B Ratio
33.5928.7937.6842.9852.96
PTB ratio
33.5928.7937.6842.9852.96
EV to sales
50.9348.4952.0952.6463.39
Enterprise value over EBITDA
155.4198.07186.6378.12164.54
EV to operating cash flow
235.39195.03685.17228.36-1.9K
EV to free cash flow
363.1408.07-2.12K-275.99-302.06
Earnings yield
0.010000
Free cash flow yield
00000
Debt to equity
1.521.691.71.82.34
Debt to assets
0.330.360.340.350.39
Net debt to EBITDA
5.9296.952.786.22
Current ratio
1.051.31.131.050.94
Interest coverage
21.8614.5317.673.6123.27
Income quality
0.821.290.36-38.14-0.14
Dividend Yield
00000
Payout ratio
0.460.760.58-17.70.46
Sales general and administrative to revenue
0.230.250.230.190.16
Research and developement to revenue
0.270.290.280.250.27
Intangibles to total assets
0.230.210.20.190.19
Capex to operating cash flow
-0.35-0.52-1.32-1.835.29
Capex to revenue
-0.08-0.13-0.1-0.42-0.18
Capex to depreciation
-1.48-2.49-2.28-9.74-4.26
Stock based compensation to revenue
0.010.020.020.020.01
Graham number
22.6819.3923.214.2324.27
ROIC
0.060.040.0600.08
Return on tangible assets
0.050.030.0400.04
Graham Net
-29.39-30.72-34.96-37.66-40.9
Working capital
896.3M4.8B2.42B1.01B-1.57B
Tangible asset value
-504.2M134.7M166.9M440.5M-982.6M
Net current asset value
-20.68B-21.06B-22.33B-23.6B-27.42B
Invested capital
1.521.691.71.82.34
Average receivables
8.44B8.79B9.1B9.77B10.85B
Average payables
1.81B1.97B2.25B2.45B2.52B
Average inventory
4.07B4.43B4.67B4.85B5.34B
Days sales outstanding
105.49116.6799.398.2109.08
Days payables outstanding
112.24111.53123.2117.82130.81
Days of inventory on hand
250.55251.45238.95237.15290.58
Receivables turnover
0.850.770.910.920.83
Payables turnover
0.80.810.730.760.69
Inventory turnover
0.360.360.380.380.31
ROE
0.180.120.16-0.010.2
Capex per share
-0.58-0.95-0.93-4.45-1.74

LLY.SW Frequently Asked Questions

What is Eli Lilly and Company stock symbol ?

Eli Lilly and Company is a US stock , located in Indianapolis of In and trading under the symbol LLY.SW

What is Eli Lilly and Company stock quote today ?

Eli Lilly and Company stock price is $660 today.

Is Eli Lilly and Company stock public?

Yes, Eli Lilly and Company is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap